Financial statements Bls Pharma W Likwidacji

Balance sheet of Bls Pharma W Likwidacji

Company age:
Age:
20 y. 7 m. 17 d.
Share capital:
Share capital:
50 000 PLN

Balance sheet data of BLS PHARMA W LIKWIDACJI

Year
2019
2021
2022
2023
Total assets 1 491 507,70 1 266 812,25 975 604,82 563 154,94
A. Fixed assets 215 981,61 186 711,29 180 382,13 0,00
B. Current assets 1 275 526,09 1 080 100,96 795 222,69 563 154,94
C. Share capital contributions (basic funds) 0,00 0,00 - 0,00
D. Own shares (stocks) 0,00 0,00 - 0,00
Total liabilities 1 491 507,70 1 266 812,25 975 604,82 563 154,94
A. Equity 1 118 661,63 933 664,77 757 010,83 556 143,94
B. Liabilities and provisions for liabilities 372 846,07 333 147,48 218 593,99 7 011,00
I. Long-term liabilities 131 069,60 0,00 0,00 0,00
II. Short-term liabilities 241 776,47 333 147,48 218 593,99 7 011,00
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.